Longitudinal single-cell and spatial transcriptomics reveals intratumor heterogeneity, therapeutic response, and comparative value of canine marginal zone lymphoma
Deep serial phenotyping is employed via serial sampling and longitudinal transcriptomics to evaluate intratumoral composition and therapy response in a 6-year-old neutered male goldendoodle with stage 5A marginal zone lymphoma to demonstrate the utility of deep serial phenotyping to track therapy response, while validating naturally occurring canine cancers as comparative models for human therapeutic development.
Abstract
Diffuse B-cell lymphomas are the most prevalent canine hematologic malignancies, and their clinical presentation resembles that of human B-cell non-Hodgkin lymphomas (NHLs). However, a lack of a clear subtyping framework perpetuates imprecise treatment approaches that fail to address mechanisms of therapy resistance. Here, we employed deep phenotyping via serial sampling and longitudinal transcriptomics to evaluate intratumoral composition and therapy response in a 6-year-old neutered male goldendoodle with stage 5A marginal zone lymphoma (MZL). Following sequential treatment consisting of a single IV dose of oncolytic vesicular stomatitis virotherapy (VSV) and standard CHOP chemotherapy 30 days later, we performed scRNAseq on seven serial lymph node biopsies and spatial sequencing on a resection taken 10 days post-VSV treatment. B cells (>90%) comprised three transcriptionally distinct and temporally stable subpopulations, with specific copy number profiles and robust spatial organization despite disrupted lymph node architecture. Analysis across subpopulations revealed downregulation of the quiescence program including KLF2, suggesting similarity to KLF2-deficient human MZL. While VSV successfully reached target B cells, downstream transcriptional responses were predominantly localized to the T-cell compartment. T cells (≤6%) showed increased proliferation and upregulation of cytotoxicity markers post-VSV administration, enriching for leukocyte-mediated cytotoxicity pathways consistent with an anti-viral immune response. Ultimately, these results provide an in vivo proof-of-concept for the treatment paradigm in canine lymphoma, while emphasizing the need for improved subtyping frameworks and multidimensional treatment strategies targeting intratumoral heterogeneity. Significance Using longitudinal single-cell and spatial transcriptomics, we mapped the molecular architecture and therapeutic response of canine marginal zone lymphoma in vivo. We identified conserved KLF2 downregulation linking canine and human MZL, alongside stable tumor heterogeneity and a distinct immune response to oncolytic virotherapy. These results demonstrate the utility of deep serial phenotyping to track therapy response, while validating naturally occurring canine cancers as comparative models for human therapeutic development.
Large B cell lymphomas (LBCLs) exhibit significant heterogeneity which leads to disparate treatment response, with up to 40% of patients developing refractory disease or relapsing within the first two years. To understand the cellular and molecular basis of this heterogeneity, we performed single-cell RNA-seq, BCR-seq,...
S. Baaklini, A. Sarrabay, C. Barthelemy et al.· Blood· 0 citations
Risk stratification in classical Hodgkin lymphoma (cHL) primarily relies on clinical and radiologic parameters, but outcomes are still heterogeneous after standard first-line chemotherapy. We investigated how, the spatial interplay between Hodgkin and Reed–Sternberg cells (HRS) and tumor microenvironment (TME) at...
B. Donati, T. Lazic, Riccardo Valli et al.· Journal of Experimental &...· 0 citations
Cutaneous T cell lymphoma (CTCL) comprises a clinically and molecularly heterogeneous group of skin-homing non-Hodgkin lymphomas for which robust biomarkers remain limited. Prior single-cell RNA sequencing (scRNA-seq) studies have provided important insights into CTCL biology, but many of these prior studies have been...
Ryan Reis, E. Mou, Vincent Liu et al.· bioRxiv· 0 citations
The tumor microenvironment (TME) of medulloblastoma (MB) influences progression and therapy response, presenting a promising target for therapeutic advances. Prior single-cell analyses have characterized the cellular components of the TME but lack spatial context. To address this, we performed spatial transcriptomic se...
F. Chien, Marina E. Michaud, Mojtaba Bakhtiari et al.· bioRxiv· 5 citations
Oral squamous cell carcinoma (OSCC) remains associated with substantial morbidity and mortality, and only a subset of patients derive durable benefit from immune-checkpoint blockade. Single-cell and spatial approaches reveal cellular states and tissue organization that bulk profiling cannot resolve. These findings sugg...
Yang Chen, Li-Rong Hou· Oncology Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.